{"id":60797,"count":1,"description":"","link":"https:\/\/www.europesays.com\/us\/tag\/immune-system-pharmacology-workplace-health-personalized-medicine-diseases-and-conditions-down-syndrome-cancer-pharmaceuticals\/","name":"Immune System; Pharmacology; Workplace Health; Personalized Medicine; Diseases and Conditions; Down Syndrome; Cancer; Pharmaceuticals","slug":"immune-system-pharmacology-workplace-health-personalized-medicine-diseases-and-conditions-down-syndrome-cancer-pharmaceuticals","taxonomy":"post_tag","meta":[],"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags\/60797","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/taxonomies\/post_tag"}],"wp:post_type":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts?tags=60797"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}